Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Anebulo Pharmaceuticals Inc
Other
Anebulo Pharmaceuticals Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
|
Other
-$320k
|
CAGR 3-Years
-152%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Other
-$1B
|
CAGR 3-Years
-237%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other
$22m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Other
-$582m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Other
-$325m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-19%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other
-$443.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-52%
|
See Also
What is Anebulo Pharmaceuticals Inc's Other?
Other
-320k
USD
Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Other amounts to -320k USD.
What is Anebulo Pharmaceuticals Inc's Other growth rate?
Other CAGR 3Y
-152%
The average annual Other growth rates for Anebulo Pharmaceuticals Inc have been -152% over the past three years .